News | December 08, 2022
Wockhardt promoters sell stake
The proceeds of the issue has been/will be reinvested in the company and to meet its own business requirements.
The proceeds of the issue has been/will be reinvested in the company and to meet its own business requirements.
The IPO is a complete OFS by existing shareholder Helix Investment Holdings
TTK Healthcare Limited received from BSV Pharma Pvt. Ltd. a sum of Rs. 593.11 crore on 9th May, 2022
To fund the upfront payment, Biocon Biologics has secured USD 1.2 billion of Sustainability Linked Loan
Gland Pharma enters into a Put Option Agreement to acquire 100% of Cenexi Group
This will enable the company to consume 100% of the solar energy to be supplied by Ethan Energy India Private Limited from their 10 MW Solar Energy plant
Acquisition expands Merck’s growing hematology portfolio
The acquisition is for an enterprise value of Rs. 218 crores
API platform to comprise of RA Chem Pharma, ZCL Chemicals and Avra Laboratories
Oncodesign Services (ODS ), with 600 clients in 33 countries and 227 employees worldwide, provides services from target identification to hit-to-lead and lead optimization through to IND filing.
Subscribe To Our Newsletter & Stay Updated
